Tenovate
Intended to relieve severe localised skin inflammation to support epidermal healing and target intense itching.
- Category
- Skin Care
- Active ingredient
- Clobetasol Propionate
- Route
- Cutaneous use
- Form
- Cream
- Strengths
- 15g · 30gm
Prescription and consultation requirements for Tenovate vary by destination and are determined by the fulfilment partner.
Tenovate details
- Conditions
- Plaque Psoriasis · Inflammatory Dermatoses
- Alternative names
- clobetasol
- Therapeutic class
- Topical Corticosteroid
- Pharmacological class
- Glucocorticoid
- Contraindications
- untreated skin infections; rosacea; hypersensitivity to clobetasol
- Minor side effects
- local skin burning; dry skin
- Moderate side effects
- skin thinning; mild striae; pruritus
- Serious side effects
- adrenal suppression, requires immediate medical attention
- Dosage forms
- Cream
- Administration route
- Cutaneous use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- GlaxoSmithKline
- Onset Time
- 1–3 days
- Duration
- 12 hours
- Storage instructions
- Store below 25°C. Do not freeze.
- Age restrictions
- Approved for children over twelve years and adults.
Patient summary
intended to relieve severe localised skin inflammation to support epidermal healing and target intense itching.
Mechanism of action
Prevents transcription of inflammatory cytokines and decreases local cell infiltration inside structural skin tissues.
Pregnancy and breastfeeding
TGA Category C: Use if potential benefits exceed risks. Breastfeeding: Consult a doctor.